Showing results (231-240 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|July 19, 2012
The effects of selenium on tumor growth in epithelial ovarian carcinomaJin Sun Park, Ji Yoon Ryu, Hye-Kyung Jeon, et al.Journal of Gynecologic Oncology|March 17, 2023
Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancerHong Chang, Ming Wang, Yang Liu, et al.Journal of Gynecologic Oncology|March 17, 2023
Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in JapanHiroshi Yoshida, Hiroko Machida, Koji Matsuo, et al.Journal of Gynecologic Oncology|February 22, 2023
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective studyLiangliang Wang, Shuangying Li, Da Zhu, et al.Journal of Gynecologic Oncology|May 28, 2020
Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologistsYingmei Wang, Shiqian Zhang, Lihui Wei, et al.Journal of Gynecologic Oncology|November 21, 2025
Impact of lymph node staging on survival in presumed early-stage ovarian cancer: a multicentric retrospective studySamia Ouasti, Julie Alline, Yohan Kerbage, et al.Journal of Gynecologic Oncology|November 21, 2025
Efficacy and safety of immune checkpoint inhibitors with chemoradiotherapy/chemotherapy in locally advanced cervical cancer patients: a systematic review and single-arm meta-analysisIfrat Jahan Piya, Israt Jahan Riya, Vivekanand SharmaJournal of Gynecologic Oncology|January 23, 2026
Prevalence of homologous recombination deficiency in ovarian, primary peritoneal, and/or fallopian tube cancer: results from HALO-Taiwan subsetWen-Shiung Liou, Angel Chao, Bor-Ching Sheu, et al.Journal of Gynecologic Oncology|January 23, 2026
Patient-centered valuation of minimally invasive surgery in cervical cancer: a discrete choice experimentJeongyun Kim, Jieun Jang, Sokbom KangJournal of Gynecologic Oncology|January 9, 2026
Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trialShuhua Wei, Xiaofan Li, Zi Liu, et al.Pageof 131